European Case Law Identifier: | ECLI:EP:BA:1986:T014483.19860327 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 27 March 1986 | ||||||||
Case number: | T 0144/83 | ||||||||
Application number: | 79300879.8 | ||||||||
IPC class: | A61K 31/445 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | A | ||||||||
Download and more information: |
|
||||||||
Title of application: | - | ||||||||
Applicant name: | Du Pont | ||||||||
Opponent name: | - | ||||||||
Board: | 3.3.01 | ||||||||
Headnote: | The fact that a chemical product has both a cosmetic and therapeutic effect when used to treat the human or animal body does not render the cosmetic treatment unpatentable (as in the present case where it may be used to cause loss of weight or to cure obesity). | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Cosmetic treatments Industrial application Biological processes (essentially) |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t830144ex1.html
Date retrieved: 17 May 2021
26 references found.
Click X to load a reference inside the current page, click on the title to open in a new page.EPO Guidelines - G Patentability
Offical Journal of the EPO
XOJ EPO SE 1/2021, p179 - Annex 1 - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2020)
XOJ EPO SE 1/2020, p174 - Annex 1 - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2019)
XOJ EPO SE 1/2019, p158 - XVI. - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2018)